4//SEC Filing
Jochelson Philip 4
Accession 0001209191-07-019575
CIK 0001339455other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 7:56 PM ET
Size
9.3 KB
Accession
0001209191-07-019575
Insider Transaction Report
Form 4
Jochelson Philip
Senior VP and Chief Medical
Transactions
- Exercise/Conversion
Common Stock
2007-03-21$2.40/sh+2,170$5,208→ 2,170 total - Sale
Common Stock
2007-03-21$13.01/sh−2,170$28,232→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2007-03-21−2,170→ 42,266 totalExercise: $2.40Exp: 2015-04-02→ Common Stock (2,170 underlying)
Footnotes (3)
- [F1]This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/11/2006, as amended to date.
- [F2]14,054 shares of common stock subject to the option are vested and exercisable as of 3/23/07 and approximately 1,128 vest and become exercisable on the first day of each month until April 1, 2009.
- [F3]Not applicable.
Documents
Issuer
Somaxon Pharmaceuticals, Inc.
CIK 0001339455
Entity typeother
Related Parties
1- filerCIK 0001346899
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 7:56 PM ET
- Size
- 9.3 KB